Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:ISRG NYSE:PATH NASDAQ:SYM On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeISRGIntuitive Surgical$411.31-0.9%$424.14$396.68▼$603.88$145.83B1.462.16 million shs710,245 shsPATHUiPath$11.79+3.2%$10.85$9.20▼$19.84$6.11B0.9836.52 million shs15.45 million shsSYMSymbotic$42.66+2.3%$47.12$38.19▼$87.88$25.81B1.931.92 million shs502,800 shs7 Stocks That Could Lead the Next Market BoomTesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceISRGIntuitive Surgical-2.86%+3.16%-0.83%-8.76%-21.28%PATHUiPath-1.93%-1.13%+1.97%+14.91%-13.73%SYMSymbotic+0.90%-7.27%-5.96%-22.21%-8.75%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeISRGIntuitive Surgical$411.31-0.9%$424.14$396.68▼$603.88$145.83B1.462.16 million shs710,245 shsPATHUiPath$11.79+3.2%$10.85$9.20▼$19.84$6.11B0.9836.52 million shs15.45 million shsSYMSymbotic$42.66+2.3%$47.12$38.19▼$87.88$25.81B1.931.92 million shs502,800 shs7 Stocks That Could Lead the Next Market BoomTesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceISRGIntuitive Surgical-2.86%+3.16%-0.83%-8.76%-21.28%PATHUiPath-1.93%-1.13%+1.97%+14.91%-13.73%SYMSymbotic+0.90%-7.27%-5.96%-22.21%-8.75%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceISRGIntuitive Surgical 2.68Moderate Buy$569.2038.39% UpsidePATHUiPath 2.06Hold$13.8017.10% UpsideSYMSymbotic 2.13Hold$65.2352.91% UpsideCurrent Analyst Ratings BreakdownLatest ISRG, SYM, and PATH Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails7/8/2026ISRGIntuitive Surgical BMO Capital MarketsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageOutperform$518.007/8/2026ISRGIntuitive Surgical CitigroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy7/7/2026SYMSymbotic Zacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeHold ➝ Strong Sell7/6/2026ISRGIntuitive Surgical EvercoreSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price Target$430.006/29/2026PATHUiPath UBS GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetNeutral$13.00 ➝ $12.006/12/2026ISRGIntuitive Surgical Bank of AmericaSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price Target$520.00 ➝ $515.006/2/2026ISRGIntuitive Surgical Piper SandlerSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingOverweight$580.006/2/2026ISRGIntuitive Surgical Deutsche Bank AktiengesellschaftSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetSell$440.00 ➝ $366.006/1/2026PATHUiPath New Street ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price Target$13.006/1/2026PATHUiPath BMO Capital MarketsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetMarket Perform$14.00 ➝ $13.005/29/2026PATHUiPath DA DavidsonSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetNeutral$13.00 ➝ $12.00(Data available from 7/9/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookISRGIntuitive Surgical$10.06B14.47$8.93 per share46.06$50.52 per share8.14PATHUiPath$1.61B3.79$0.39 per share29.84$3.88 per share3.04SYMSymbotic$2.25B11.44$0.05 per share897.89$0.82 per share52.02Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateISRGIntuitive Surgical$2.86B$8.2549.9141.883.4828.15%15.98%14.07%7/16/2026 (Estimated)PATHUiPath$282.33M$0.6019.6624.051.4019.58%7.92%5.19%9/3/2026 (Estimated)SYMSymbotic-$16.94M-$0.05N/A46.376.09-0.20%-0.68%-0.19%8/5/2026 (Estimated)Latest ISRG, SYM, and PATH EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/5/2026Q3 2026SYMSymbotic$0.12N/AN/AN/A$715.15 millionN/A7/16/2026Q2 2026ISRGIntuitive Surgical$2.48N/AN/AN/A$2.82 billionN/A5/28/2026Q1 2027PATHUiPath$0.15$0.15N/A$0.04$397.54 million$418.38 million5/6/2026Q2 2026SYMSymbotic$0.1167$0.01-$0.1067$0.01$662.66 million$676.48 million4/21/2026Q1 2026ISRGIntuitive Surgical$2.08$2.50+$0.42$2.28$2.62 billion$2.77 billionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthISRGIntuitive SurgicalN/AN/AN/AN/AN/APATHUiPathN/AN/AN/AN/AN/ASYMSymboticN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioISRGIntuitive SurgicalN/A4.613.59PATHUiPathN/A2.312.31SYMSymboticN/A1.451.35Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipISRGIntuitive Surgical83.64%PATHUiPath62.50%SYMSymboticN/AInsider OwnershipCompanyInsider OwnershipISRGIntuitive Surgical0.60%PATHUiPath22.44%SYMSymbotic8.16%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableISRGIntuitive Surgical17,021354.16 million352.04 millionOptionablePATHUiPath3,981518.12 million401.85 millionOptionableSYMSymbotic2,000602.71 million553.53 millionNot OptionableISRG, SYM, and PATH HeadlinesRecent News About These CompaniesSymbotic (NASDAQ:SYM) Cut to Strong Sell at Zacks Research4 hours ago | marketbeat.comSymbotic (NASDAQ:SYM) Director Sells 2,000 Shares of StockJuly 9 at 6:52 AM | insidertrades.comSymbotic (NASDAQ:SYM) Director Sells $87,840.00 in StockJuly 8 at 7:07 PM | marketbeat.comSymbotic (NASDAQ:SYM) Director Sells 3,367 Shares of StockJuly 8 at 7:07 PM | marketbeat.comSymbotic (SYM) Stock Still Looks Cheap Following Its 315% RunJuly 8 at 7:51 AM | finance.yahoo.comSymbotic (SYM) Could Be 32% Undervalued On Its Warehouse Automation NarrativeJuly 7 at 7:43 PM | finance.yahoo.comSymbotic Inc. (SYM) Dips More Than Broader Market: What You Should KnowJuly 7 at 7:43 PM | finance.yahoo.comSymbotic Inc. (SYM) Dips More Than Broader Market: What You Should KnowJuly 7 at 7:16 PM | zacks.comSymbotic (NASDAQ:SYM) Director Sells 2,000 SharesJuly 7 at 9:36 AM | insidertrades.comCharles Kane Sells 2,000 Shares of Symbotic (NASDAQ:SYM) StockJuly 7 at 8:38 AM | americanbankingnews.comSymbotic (NASDAQ:SYM) Insider Sells 5,115 SharesJuly 7 at 8:38 AM | americanbankingnews.comYMM vs. SYM: Which Stock Is the Better Value Option?July 6 at 3:00 PM | finance.yahoo.comYMM vs. SYM: Which Stock Is the Better Value Option?July 6 at 12:40 PM | zacks.comJim Cramer on Symbotic: “I Think It’s a Decent Spec, and It’s Too Low”July 3, 2026 | finance.yahoo.comPeregrine Asset Advisers Inc. Takes $2.38 Million Position in Symbotic Inc. $SYMJuly 3, 2026 | marketbeat.comJim Cramer on Symbotic: “I Think It’s a Decent Spec, and It’s Too Low”July 3, 2026 | insidermonkey.comThe First Major Robotics IPO Is Here: 5 Robotics Stocks That Could Run in the Second Half of 2026July 2, 2026 | 247wallst.comSymbotic Inc. (SYM) Is a Trending Stock: Facts to Know Before Betting on ItJuly 2, 2026 | zacks.comSymbotic Announces Acquisition of ARMS Innovations, Advancing a New Era of Warehouse Operations OptimizationJuly 2, 2026 | finance.yahoo.comSymbotic Announces Acquisition of ARMS Innovations, Advancing a New Era of Warehouse Operations OptimizationJuly 2, 2026 | globenewswire.comSymbotic Inc. (SYM) Laps the Stock Market: Here's WhyJune 29, 2026 | finance.yahoo.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeISRG, SYM, and PATH Company DescriptionsIntuitive Surgical NASDAQ:ISRG$411.31 -3.79 (-0.91%) As of 12:28 PM Eastern This is a fair market value price provided by Massive. Learn more.Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. The company sells its products through direct sales organizations, such as capital and clinical sales teams. It has a collaboration agreement with FluoGuide A/S for head & neck cancer. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.UiPath NYSE:PATH$11.78 +0.37 (+3.20%) As of 12:28 PM Eastern This is a fair market value price provided by Massive. Learn more.UiPath Inc. provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization. Its platform's embedded AI, ML, and NLP capabilities improve decisioning and information processing; emulate human behavior allows organizations to address a myriad of use cases; emulate human behavior allows organizations to address a myriad of use cases; multi-tenant platform enterprise deployment with security and governance and Automation Cloud, which enables customers to begin automating without the need to provision infrastructure, install applications, or perform additional configurations; intuitive interface and low-code, drag-and-drop functionality; signed to enable people and automations to work together; and tracks, measures, and forecasts the performance of automations, enables customers to gain powerful insights and generate key performance indicators with actionable metric. It serves banking and financial services, healthcare, insurance, public sectors, manufacturing, retail, and telecom industries. The company was founded in 2005 and is headquartered in New York, New York.Symbotic NASDAQ:SYM$42.66 +0.97 (+2.33%) As of 12:28 PM Eastern This is a fair market value price provided by Massive. Learn more.Symbotic Inc., an automation technology company, engages in developing technologies to improve operating efficiencies in modern warehouses. The company automates the processing of pallets and cases in large warehouses or distribution centers for retail companies. Its systems enhance operations at the front end of the supply chain. The company was founded in 2006 and is headquartered in Wilmington, Massachusetts. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Lockheed Martin Secures the Ultimate Defense Moat Constellation Brands: Beer Growth and Buybacks Mask Stock's Slump Grounded: SpaceX Stumbles as Grok Fails to Ignite Southwest MAX Incident Revives Headline Risk for Boeing and Airline Stocks Fiserv’s Debit Network Talks Raise a Bigger Question for Visa and Mastercard Rivian’s 75 Million-Share Offering Turns the R2 Growth Story Into a Dilution Test Sony Is Going All-Digital—But Investors Should Watch This Instead Scotiabank Sees a New Growth Story for Cloudflare Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
